Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality

References

• Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5(12):939–951.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bano J, Garcia L, Ramirez E, et al. Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive “bundle” approach. Am J Infect Control. 2009;37(9):715–722.
   PubMed Web of Science ®Google Scholar
• Kempf M, Rolain JM. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents. 2012;39(2):105–114.
   PubMed Web of Science ®Google Scholar
• Qureshi ZA, Hittle LE, O’Hara JA, et al. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance. Clin Infect Dis. 2015;60(9):1295–1303.
   PubMed Web of Science ®Google Scholar
• Villar M, Cano ME, Gato E, et al; GEIH/GEMARA/REIPI-Ab20101 Group. Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal. Medicine (Baltimore). 2014;93(5):202–210.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bano J, Cisneros JM, Fernandez-Cuenca F, et al; Grupo de Estudio de Infecciôn Hospitalaria (GEIH). Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect ControlHosp Epidemiol. 2004;25(10):819–824.
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Cataldo MA, De Pascale G, et al. Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. J Antimicrob Chemother. 2008;62(5):1130–1137.
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Edmond MB, Pfaller MA, Jones RN, Wenzel RP, Seifert H. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis. 2000;31(3):690–697.
   PubMed Web of Science ®Google Scholar
• Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect. 2002;8(11):687–693.
   PubMed Web of Science ®Google Scholar
• Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006;42(5):692–699.
   PubMed Web of Science ®Google Scholar
• Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–582.
   PubMed Web of Science ®Google Scholar
• Guerrero-Lozano I, Fernandez-Cuenca F, Galan-Sanchez F, Egea P, Rodriguez-Iglesias M, Pascual A. Description of the OXA-23 β-lactamase gene located within Tn2007 in a clinical isolate of Acinetobacter baumannii from Spain. Microb Drug Resist. 2015;21(2):215–217.
   PubMed Web of Science ®Google Scholar
• Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–332.
   PubMed Web of Science ®Google Scholar
• Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791–797.
   PubMed Web of Science ®Google Scholar
• McCabe WR, Jackson GG. Gram-negative bacteremia I. Etiology and ecology. Arch Intern Med. 1962;110(6):847–855.
   Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–829.
   PubMed Web of Science ®Google Scholar
• Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31(4):1250–1256.
   Google Scholar
• Clinical and CLSI, Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing-20th Informational Supplement. Approved Standard M100-S20. Wayne, PA: NCCLS; 2010.
   Google Scholar
• Fernandez Cuenca F, Tomas Carmona M, Caballero Moyano F, et al. Actividad de 18 agentes antimicrobianos frente a aislados clinicos de Acinetobacter baumannii: segundo estudio nacional multicentrico (proyecto GEIH-REIPI-Ab 2010). Enferm Infecc Microbiol Clin. 2013;31(1):4–9.
   PubMedGoogle Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281.
   PubMed Web of Science ®Google Scholar
• Livermore DM, Hill RL, Thomson H, et al; C-MRAB Study Group. Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London. Int J Antimicrob Agents. 2010;35(1):19–24.
   PubMed Web of Science ®Google Scholar
• Kollef MH, Golan Y, Micek ST, Shorr AF, Restrepo MI. Appraising contemporary strategies to combat multidrug resistant Gram-negative bacterial infections-proceedings and data from the Gram-negative resistance summit. Clin Infect Dis. 2011;53(suppl 2):S33-S55.
   PubMedGoogle Scholar
• Corbella X, Montero A, Pujol M, et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol. 2000;38(11):4086–4095.
   PubMed Web of Science ®Google Scholar
• Playford EG, Craig JC, Iredell JR. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect. 2007;65(3):204–211.
   PubMed Web of Science ®Google Scholar
• Arvaniti K, Lathyris D, Ruimy R, et al. The importance of colonization pressure in multiresistant Acinetobacter baumannii acquisition in a Greek intensive care unit. Crit Care. 2012;16(3):R102.
   PubMed Web of Science ®Google Scholar
• Vasudevan A, Mukhopadhyay A, Li J, Yuen EG, Tambyah PA. A prediction tool for nosocomial multi-drug resistant Gram-negative bacilli infections in critically ill patients - prospective observational study. BMC Infect Dis. 2014;14:615.
   PubMed Web of Science ®Google Scholar
• Hernandez-Torres A, Garcia-Vazquez E, Gômez J, et al. Colonizaciôn/infecciôn por Acinetobacter baumannii multirresistente y resistente a carbapenémicos: epidemiologia y factores predictivos de infecciôn. Med Clin (Barc). 2010;135(9):389–396.
   PubMedGoogle Scholar
• Munoz-Price LS, Arheart K, Nordmann P, et al. Eighteen years of experience with Acinetobacter baumannii in a tertiary care hospital. Crit Care Med. 2013;41(12):2733–2742.
   PubMed Web of Science ®Google Scholar
• Martin-Loeches I, Povoa P, Rodriguez A, et al; TAVeM Study. Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicenter, prospective, observational study. Lancet Respir Med. 2015;3(11):859–868.
   Google Scholar
• Dallas J, Skrupky L, Abebe N, Boyle WA, Kollef MH. Ventilator-associated tracheobronchitis in a mixed surgical and medical ICU population. Chest. 2011;139(3):513–518.
   PubMed Web of Science ®Google Scholar
• Craven DE, Lei Y, Ruthazer R, Sarwar A, Hudcova J. Incidence and outcomes of ventilator-associated tracheobronchitis and pneumonia. Am J Med. 2013;126(6):542–549.
   PubMed Web of Science ®Google Scholar
• Bouza E, Pérez A, Munoz P, et al; Cardiovascular Infection Study Group. Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance. Crit Care Med. 2003;31(7):1964–1970.
   PubMed Web of Science ®Google Scholar
• Craven DE, Chroneou A, Zias N, Hjalmarson KI. Ventilator-associated tracheobronchitis: the impact of targeted antibiotic therapy on patient outcomes. Chest. 2009;135(2):521–528.
   PubMed Web of Science ®Google Scholar
• Lemos EV de la Hoz FP, Einarson TR, et al. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin Microbiol Infect. 2014;20(5):416–423.
   PubMed Web of Science ®Google Scholar
• Falagas ME, Rafailidis PI. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit Care. 2007;11(3):134.
   PubMed Web of Science ®Google Scholar
• Lôpez-Cortés LE, Cisneros JM, Fernandez-Cuenca F, et al; GEIH/REIPI-Ab2010 Group. Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort. J Antimicrob Chemother. 2014;69(11):3119–3126.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Duan J. Nosocomial pneumonia in non-invasive ventilation patients: incidence, characteristics, and outcomes. JHosp Infect. 2015;91(2):153–157.
   Web of Science ®Google Scholar
• Yang YS, Lee YT, Huang TW, et al. Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients? BMC Infect Dis. 2013;13:142.
   PubMed Web of Science ®Google Scholar
• del Mar Tomas M, Cartelle M, Pertega S, et al. Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect. 2005;11(7):540–546.
   PubMed Web of Science ®Google Scholar